ID   AVR2A_HUMAN             Reviewed;         513 AA.
AC   P27037; B2RAB8; B4DWQ2; D3DP85; Q53TH4; Q6NWV2; Q92474;
DT   01-AUG-1992, integrated into UniProtKB/Swiss-Prot.
DT   01-AUG-1992, sequence version 1.
DT   12-OCT-2022, entry version 220.
DE   RecName: Full=Activin receptor type-2A;
DE            EC=2.7.11.30;
DE   AltName: Full=Activin receptor type IIA;
DE            Short=ACTR-IIA;
DE            Short=ACTRIIA;
DE   Flags: Precursor;
GN   Name=ACVR2A; Synonyms=ACVR2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Testis;
RX   PubMed=1311955; DOI=10.1016/0167-4781(92)90472-c;
RA   Matzuk M.M., Bradley A.;
RT   "Cloning of the human activin receptor cDNA reveals high evolutionary
RT   conservation.";
RL   Biochim. Biophys. Acta 1130:105-108(1992).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND FUNCTION.
RC   TISSUE=Testis;
RX   PubMed=1314589; DOI=10.1016/0006-291x(92)91194-u;
RA   Donaldson C.J., Mathews L.S., Vale W.W.;
RT   "Molecular cloning and binding properties of the human type II activin
RT   receptor.";
RL   Biochem. Biophys. Res. Commun. 184:310-316(1992).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Mammary gland;
RA   Geiser A.G.;
RL   Submitted (DEC-1991) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RA   Iimura T., Oida S.;
RL   Submitted (NOV-1994) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Colon, and Hippocampus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H., Minx P.,
RA   Wagner-McPherson C., Layman D., Wylie K., Sekhon M., Becker M.C.,
RA   Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E., Kremitzki C., Oddy L.,
RA   Du H., Sun H., Bradshaw-Cordum H., Ali J., Carter J., Cordes M., Harris A.,
RA   Isak A., van Brunt A., Nguyen C., Du F., Courtney L., Kalicki J.,
RA   Ozersky P., Abbott S., Armstrong J., Belter E.A., Caruso L., Cedroni M.,
RA   Cotton M., Davidson T., Desai A., Elliott G., Erb T., Fronick C., Gaige T.,
RA   Haakenson W., Haglund K., Holmes A., Harkins R., Kim K., Kruchowski S.S.,
RA   Strong C.M., Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N., Swearengen-Shahid S.,
RA   Snider J., Strong J.T., Thompson J., Yoakum M., Leonard S., Pearman C.,
RA   Trani L., Radionenko M., Waligorski J.E., Wang C., Rock S.M.,
RA   Tin-Wollam A.-M., Maupin R., Latreille P., Wendl M.C., Yang S.-P., Pohl C.,
RA   Wallis J.W., Spieth J., Bieri T.A., Berkowicz N., Nelson J.O., Osborne J.,
RA   Ding L., Meyer R., Sabo A., Shotland Y., Sinha P., Wohldmann P.E.,
RA   Cook L.L., Hickenbotham M.T., Eldred J., Williams D., Jones T.A., She X.,
RA   Ciccarelli F.D., Izaurralde E., Taylor J., Schmutz J., Myers R.M.,
RA   Cox D.R., Huang X., McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D., Waterston R.H.,
RA   Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2 and
RT   4.";
RL   Nature 434:724-731(2005).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [9]
RP   INTERACTION WITH BMP7.
RX   PubMed=12667445; DOI=10.1016/s1097-2765(03)00094-7;
RA   Greenwald J., Groppe J., Gray P., Wiater E., Kwiatkowski W., Vale W.,
RA   Choe S.;
RT   "The BMP7/ActRII extracellular domain complex provides new insights into
RT   the cooperative nature of receptor assembly.";
RL   Mol. Cell 11:605-617(2003).
RN   [10]
RP   FUNCTION, AND INTERACTION WITH ACVR1.
RX   PubMed=17911401; DOI=10.1677/joe-07-0281;
RA   Renlund N., O'Neill F.H., Zhang L., Sidis Y., Teixeira J.;
RT   "Activin receptor-like kinase-2 inhibits activin signaling by blocking the
RT   binding of activin to its type II receptor.";
RL   J. Endocrinol. 195:95-103(2007).
RN   [11]
RP   X-RAY CRYSTALLOGRAPHY (1.96 ANGSTROMS) OF 191-488 IN COMPLEX WITH
RP   DORSOMORPHIN.
RG   Structural genomics consortium (SGC);
RT   "Crystal structure of activin receptor type-IIa (ACVR2A) kinase domain in
RT   complex with dorsomorphin.";
RL   Submitted (FEB-2011) to the PDB data bank.
RN   [12]
RP   VARIANTS ARG-258 AND ASN-306.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C., Bignell G.,
RA   Davies H., Teague J., Butler A., Stevens C., Edkins S., O'Meara S.,
RA   Vastrik I., Schmidt E.E., Avis T., Barthorpe S., Bhamra G., Buck G.,
RA   Choudhury B., Clements J., Cole J., Dicks E., Forbes S., Gray K.,
RA   Halliday K., Harrison R., Hills K., Hinton J., Jenkinson A., Jones D.,
RA   Menzies A., Mironenko T., Perry J., Raine K., Richardson D., Shepherd R.,
RA   Small A., Tofts C., Varian J., Webb T., West S., Widaa S., Yates A.,
RA   Cahill D.P., Louis D.N., Goldstraw P., Nicholson A.G., Brasseur F.,
RA   Looijenga L., Weber B.L., Chiew Y.-E., DeFazio A., Greaves M.F.,
RA   Green A.R., Campbell P., Birney E., Easton D.F., Chenevix-Trench G.,
RA   Tan M.-H., Khoo S.K., Teh B.T., Yuen S.T., Leung S.Y., Wooster R.,
RA   Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
RN   [13]
RP   VARIANT THR-367.
RX   PubMed=21248752; DOI=10.1038/nature09639;
RA   Varela I., Tarpey P., Raine K., Huang D., Ong C.K., Stephens P., Davies H.,
RA   Jones D., Lin M.L., Teague J., Bignell G., Butler A., Cho J.,
RA   Dalgliesh G.L., Galappaththige D., Greenman C., Hardy C., Jia M.,
RA   Latimer C., Lau K.W., Marshall J., McLaren S., Menzies A., Mudie L.,
RA   Stebbings L., Largaespada D.A., Wessels L.F.A., Richard S., Kahnoski R.J.,
RA   Anema J., Tuveson D.A., Perez-Mancera P.A., Mustonen V., Fischer A.,
RA   Adams D.J., Rust A., Chan-On W., Subimerb C., Dykema K., Furge K.,
RA   Campbell P.J., Teh B.T., Stratton M.R., Futreal P.A.;
RT   "Exome sequencing identifies frequent mutation of the SWI/SNF complex gene
RT   PBRM1 in renal carcinoma.";
RL   Nature 469:539-542(2011).
CC   -!- FUNCTION: On ligand binding, forms a receptor complex consisting of two
CC       type II and two type I transmembrane serine/threonine kinases. Type II
CC       receptors phosphorylate and activate type I receptors which
CC       autophosphorylate, then bind and activate SMAD transcriptional
CC       regulators. Receptor for activin A, activin B and inhibin A
CC       (PubMed:17911401). Mediates induction of adipogenesis by GDF6 (By
CC       similarity). {ECO:0000250|UniProtKB:P27038, ECO:0000269|PubMed:1314589,
CC       ECO:0000269|PubMed:17911401}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-threonyl-[receptor-protein] = ADP + H(+) + O-phospho-
CC         L-threonyl-[receptor-protein]; Xref=Rhea:RHEA:44880, Rhea:RHEA-
CC         COMP:11024, Rhea:RHEA-COMP:11025, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:30013, ChEBI:CHEBI:30616, ChEBI:CHEBI:61977,
CC         ChEBI:CHEBI:456216; EC=2.7.11.30;
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-seryl-[receptor-protein] = ADP + H(+) + O-phospho-L-
CC         seryl-[receptor-protein]; Xref=Rhea:RHEA:18673, Rhea:RHEA-COMP:11022,
CC         Rhea:RHEA-COMP:11023, ChEBI:CHEBI:15378, ChEBI:CHEBI:29999,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:83421, ChEBI:CHEBI:456216;
CC         EC=2.7.11.30;
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420; Evidence={ECO:0000250};
CC       Name=Mn(2+); Xref=ChEBI:CHEBI:29035; Evidence={ECO:0000250};
CC   -!- SUBUNIT: Interacts with AIP1. Part of a complex consisting of AIP1,
CC       ACVR2A, ACVR1B and SMAD3 (By similarity). Interacts with type I
CC       receptor ACVR1 (PubMed:17911401). Interacts with BMP7
CC       (PubMed:12667445). {ECO:0000250|UniProtKB:P27038,
CC       ECO:0000269|PubMed:12667445, ECO:0000269|PubMed:17911401}.
CC   -!- SUBCELLULAR LOCATION: Membrane; Single-pass type I membrane protein.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P27037-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P27037-2; Sequence=VSP_054689;
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. TKL Ser/Thr
CC       protein kinase family. TGFB receptor subfamily. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology and
CC       Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/ACVR2ID567ch2q22.html";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X63128; CAA44839.1; -; mRNA.
DR   EMBL; M93415; AAA35504.1; -; mRNA.
DR   EMBL; X62381; CAA44245.1; -; mRNA.
DR   EMBL; D31770; BAA06548.1; -; mRNA.
DR   EMBL; AK301629; BAG63114.1; -; mRNA.
DR   EMBL; AK314124; BAG36815.1; -; mRNA.
DR   EMBL; AC009480; AAX93050.1; -; Genomic_DNA.
DR   EMBL; CH471058; EAX11561.1; -; Genomic_DNA.
DR   EMBL; CH471058; EAX11562.1; -; Genomic_DNA.
DR   EMBL; BC067418; AAH67418.1; -; mRNA.
DR   EMBL; BC067417; AAH67417.1; -; mRNA.
DR   EMBL; BC069707; AAH69707.1; -; mRNA.
DR   CCDS; CCDS33301.1; -. [P27037-1]
DR   CCDS; CCDS63030.1; -. [P27037-2]
DR   PIR; JQ1486; JQ1486.
DR   RefSeq; NP_001265508.1; NM_001278579.1. [P27037-1]
DR   RefSeq; NP_001265509.1; NM_001278580.1. [P27037-2]
DR   RefSeq; NP_001607.1; NM_001616.4. [P27037-1]
DR   PDB; 3Q4T; X-ray; 1.96 A; A/B=191-488.
DR   PDB; 3SOC; X-ray; 1.95 A; A/B=191-488.
DR   PDB; 4ASX; X-ray; 2.05 A; A/B=191-488.
DR   PDB; 5NH3; X-ray; 2.35 A; A/B=20-135.
DR   PDBsum; 3Q4T; -.
DR   PDBsum; 3SOC; -.
DR   PDBsum; 4ASX; -.
DR   PDBsum; 5NH3; -.
DR   AlphaFoldDB; P27037; -.
DR   SMR; P27037; -.
DR   BioGRID; 106607; 126.
DR   DIP; DIP-520N; -.
DR   IntAct; P27037; 21.
DR   MINT; P27037; -.
DR   STRING; 9606.ENSP00000241416; -.
DR   BindingDB; P27037; -.
DR   ChEMBL; CHEMBL5616; -.
DR   DrugBank; DB12118; Sotatercept.
DR   DrugCentral; P27037; -.
DR   GuidetoPHARMACOLOGY; 1791; -.
DR   GlyGen; P27037; 2 sites.
DR   iPTMnet; P27037; -.
DR   PhosphoSitePlus; P27037; -.
DR   BioMuta; ACVR2A; -.
DR   DMDM; 114722; -.
DR   EPD; P27037; -.
DR   jPOST; P27037; -.
DR   MassIVE; P27037; -.
DR   MaxQB; P27037; -.
DR   PaxDb; P27037; -.
DR   PeptideAtlas; P27037; -.
DR   PRIDE; P27037; -.
DR   ProteomicsDB; 5369; -.
DR   ProteomicsDB; 54373; -. [P27037-1]
DR   ABCD; P27037; 1 sequenced antibody.
DR   Antibodypedia; 18817; 499 antibodies from 37 providers.
DR   DNASU; 92; -.
DR   Ensembl; ENST00000241416.12; ENSP00000241416.7; ENSG00000121989.15. [P27037-1]
DR   Ensembl; ENST00000404590.1; ENSP00000384338.1; ENSG00000121989.15. [P27037-1]
DR   Ensembl; ENST00000535787.5; ENSP00000439988.1; ENSG00000121989.15. [P27037-2]
DR   GeneID; 92; -.
DR   KEGG; hsa:92; -.
DR   MANE-Select; ENST00000241416.12; ENSP00000241416.7; NM_001616.5; NP_001607.1.
DR   UCSC; uc002twg.5; human. [P27037-1]
DR   CTD; 92; -.
DR   DisGeNET; 92; -.
DR   GeneCards; ACVR2A; -.
DR   HGNC; HGNC:173; ACVR2A.
DR   HPA; ENSG00000121989; Low tissue specificity.
DR   MalaCards; ACVR2A; -.
DR   MIM; 102581; gene.
DR   neXtProt; NX_P27037; -.
DR   OpenTargets; ENSG00000121989; -.
DR   PharmGKB; PA24494; -.
DR   VEuPathDB; HostDB:ENSG00000121989; -.
DR   eggNOG; KOG3653; Eukaryota.
DR   GeneTree; ENSGT00940000157233; -.
DR   HOGENOM; CLU_000288_8_4_1; -.
DR   InParanoid; P27037; -.
DR   OMA; IICAFWV; -.
DR   OrthoDB; 390511at2759; -.
DR   PhylomeDB; P27037; -.
DR   TreeFam; TF352876; -.
DR   BRENDA; 2.7.10.2; 2681.
DR   PathwayCommons; P27037; -.
DR   Reactome; R-HSA-1181150; Signaling by NODAL.
DR   Reactome; R-HSA-1433617; Regulation of signaling by NODAL.
DR   Reactome; R-HSA-1502540; Signaling by Activin.
DR   Reactome; R-HSA-201451; Signaling by BMP.
DR   SignaLink; P27037; -.
DR   SIGNOR; P27037; -.
DR   BioGRID-ORCS; 92; 40 hits in 1098 CRISPR screens.
DR   ChiTaRS; ACVR2A; human.
DR   EvolutionaryTrace; P27037; -.
DR   GeneWiki; ACVR2A; -.
DR   GenomeRNAi; 92; -.
DR   Pharos; P27037; Tchem.
DR   PRO; PR:P27037; -.
DR   Proteomes; UP000005640; Chromosome 2.
DR   RNAct; P27037; protein.
DR   Bgee; ENSG00000121989; Expressed in buccal mucosa cell and 201 other tissues.
DR   Genevisible; P27037; HS.
DR   GO; GO:0048179; C:activin receptor complex; IBA:GO_Central.
DR   GO; GO:0009986; C:cell surface; IEA:Ensembl.
DR   GO; GO:0005737; C:cytoplasm; IDA:HGNC-UCL.
DR   GO; GO:0034673; C:inhibin-betaglycan-ActRII complex; IDA:BHF-UCL.
DR   GO; GO:0005887; C:integral component of plasma membrane; TAS:ProtInc.
DR   GO; GO:0005886; C:plasma membrane; IBA:GO_Central.
DR   GO; GO:0043235; C:receptor complex; IPI:BHF-UCL.
DR   GO; GO:0048185; F:activin binding; IEA:Ensembl.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0098821; F:BMP receptor activity; ISS:UniProtKB.
DR   GO; GO:0015026; F:coreceptor activity; IDA:BHF-UCL.
DR   GO; GO:0019838; F:growth factor binding; IEA:Ensembl.
DR   GO; GO:0034711; F:inhibin binding; IEA:Ensembl.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0030165; F:PDZ domain binding; IEA:Ensembl.
DR   GO; GO:0043621; F:protein self-association; IEA:Ensembl.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; EXP:Reactome.
DR   GO; GO:0004675; F:transmembrane receptor protein serine/threonine kinase activity; TAS:ProtInc.
DR   GO; GO:0032924; P:activin receptor signaling pathway; IMP:BHF-UCL.
DR   GO; GO:0009952; P:anterior/posterior pattern specification; IEA:Ensembl.
DR   GO; GO:0030509; P:BMP signaling pathway; IDA:BHF-UCL.
DR   GO; GO:0071773; P:cellular response to BMP stimulus; IMP:BHF-UCL.
DR   GO; GO:0071363; P:cellular response to growth factor stimulus; IBA:GO_Central.
DR   GO; GO:0007368; P:determination of left/right symmetry; IEA:Ensembl.
DR   GO; GO:0048706; P:embryonic skeletal system development; IEA:Ensembl.
DR   GO; GO:0001702; P:gastrulation with mouth forming second; IEA:Ensembl.
DR   GO; GO:0007498; P:mesoderm development; IEA:Ensembl.
DR   GO; GO:0042475; P:odontogenesis of dentin-containing tooth; IEA:Ensembl.
DR   GO; GO:0043084; P:penile erection; IEA:Ensembl.
DR   GO; GO:0032927; P:positive regulation of activin receptor signaling pathway; IDA:HGNC-UCL.
DR   GO; GO:0030501; P:positive regulation of bone mineralization; IMP:BHF-UCL.
DR   GO; GO:0045648; P:positive regulation of erythrocyte differentiation; IDA:HGNC-UCL.
DR   GO; GO:0045669; P:positive regulation of osteoblast differentiation; IMP:BHF-UCL.
DR   GO; GO:0010862; P:positive regulation of pathway-restricted SMAD protein phosphorylation; IMP:BHF-UCL.
DR   GO; GO:0001934; P:positive regulation of protein phosphorylation; IMP:MGI.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; IMP:BHF-UCL.
DR   GO; GO:0006468; P:protein phosphorylation; IBA:GO_Central.
DR   GO; GO:0050999; P:regulation of nitric-oxide synthase activity; IEA:Ensembl.
DR   GO; GO:0060011; P:Sertoli cell proliferation; IEA:Ensembl.
DR   GO; GO:0042713; P:sperm ejaculation; IEA:Ensembl.
DR   GO; GO:0007283; P:spermatogenesis; IEA:Ensembl.
DR   GO; GO:0007178; P:transmembrane receptor protein serine/threonine kinase signaling pathway; TAS:ProtInc.
DR   Gene3D; 2.10.60.10; -; 1.
DR   InterPro; IPR000472; Activin_recp.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   InterPro; IPR045860; Snake_toxin-like_sf.
DR   InterPro; IPR000333; TGFB_receptor.
DR   PANTHER; PTHR23255; PTHR23255; 1.
DR   Pfam; PF01064; Activin_recp; 1.
DR   Pfam; PF00069; Pkinase; 1.
DR   PRINTS; PR00653; ACTIVIN2R.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   SUPFAM; SSF57302; SSF57302; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; ATP-binding; Disulfide bond;
KW   Glycoprotein; Kinase; Magnesium; Manganese; Membrane; Metal-binding;
KW   Nucleotide-binding; Receptor; Reference proteome;
KW   Serine/threonine-protein kinase; Signal; Transferase; Transmembrane;
KW   Transmembrane helix.
FT   SIGNAL          1..19
FT                   /evidence="ECO:0000255"
FT   CHAIN           20..513
FT                   /note="Activin receptor type-2A"
FT                   /id="PRO_0000024398"
FT   TOPO_DOM        20..135
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        136..161
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        162..513
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          192..485
FT                   /note="Protein kinase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   ACT_SITE        322
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159,
FT                   ECO:0000255|PROSITE-ProRule:PRU10027"
FT   BINDING         198..206
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   BINDING         219
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   CARBOHYD        43
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        66
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        30..60
FT                   /evidence="ECO:0000250|UniProtKB:P27038"
FT   DISULFID        50..78
FT                   /evidence="ECO:0000250|UniProtKB:P27038"
FT   DISULFID        85..104
FT                   /evidence="ECO:0000250|UniProtKB:P27038"
FT   DISULFID        91..103
FT                   /evidence="ECO:0000250|UniProtKB:P27038"
FT   DISULFID        105..110
FT                   /evidence="ECO:0000250|UniProtKB:P27038"
FT   VAR_SEQ         1..108
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_054689"
FT   VARIANT         258
FT                   /note="S -> R (in dbSNP:rs34917571)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_032809"
FT   VARIANT         306
FT                   /note="D -> N (in a gastric adenocarcinoma sample; somatic
FT                   mutation; dbSNP:rs764255410)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_032810"
FT   VARIANT         367
FT                   /note="A -> T (found in a clear cell renal carcinoma case;
FT                   somatic mutation)"
FT                   /evidence="ECO:0000269|PubMed:21248752"
FT                   /id="VAR_064692"
FT   CONFLICT        13
FT                   /note="L -> V (in Ref. 4; BAA06548)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        204..206
FT                   /note="GCV -> PSL (in Ref. 4; BAA06548)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        348
FT                   /note="E -> V (in Ref. 4; BAA06548)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        507
FT                   /note="P -> L (in Ref. 8; AAH67417)"
FT                   /evidence="ECO:0000305"
FT   STRAND          28..34
FT                   /evidence="ECO:0007829|PDB:5NH3"
FT   HELIX           37..40
FT                   /evidence="ECO:0007829|PDB:5NH3"
FT   STRAND          44..49
FT                   /evidence="ECO:0007829|PDB:5NH3"
FT   STRAND          58..67
FT                   /evidence="ECO:0007829|PDB:5NH3"
FT   STRAND          70..80
FT                   /evidence="ECO:0007829|PDB:5NH3"
FT   STRAND          95..97
FT                   /evidence="ECO:0007829|PDB:5NH3"
FT   STRAND          99..105
FT                   /evidence="ECO:0007829|PDB:5NH3"
FT   HELIX           110..112
FT                   /evidence="ECO:0007829|PDB:5NH3"
FT   STRAND          191..199
FT                   /evidence="ECO:0007829|PDB:3SOC"
FT   STRAND          205..211
FT                   /evidence="ECO:0007829|PDB:3SOC"
FT   STRAND          214..221
FT                   /evidence="ECO:0007829|PDB:3SOC"
FT   HELIX           223..225
FT                   /evidence="ECO:0007829|PDB:3SOC"
FT   HELIX           226..236
FT                   /evidence="ECO:0007829|PDB:3SOC"
FT   STRAND          249..256
FT                   /evidence="ECO:0007829|PDB:3SOC"
FT   STRAND          258..268
FT                   /evidence="ECO:0007829|PDB:3SOC"
FT   HELIX           275..281
FT                   /evidence="ECO:0007829|PDB:3SOC"
FT   HELIX           286..303
FT                   /evidence="ECO:0007829|PDB:3SOC"
FT   STRAND          307..310
FT                   /evidence="ECO:0007829|PDB:3SOC"
FT   STRAND          313..315
FT                   /evidence="ECO:0007829|PDB:3SOC"
FT   STRAND          317..319
FT                   /evidence="ECO:0007829|PDB:3SOC"
FT   STRAND          327..330
FT                   /evidence="ECO:0007829|PDB:3SOC"
FT   STRAND          336..338
FT                   /evidence="ECO:0007829|PDB:3SOC"
FT   STRAND          345..347
FT                   /evidence="ECO:0007829|PDB:3SOC"
FT   HELIX           363..365
FT                   /evidence="ECO:0007829|PDB:3SOC"
FT   HELIX           368..371
FT                   /evidence="ECO:0007829|PDB:3SOC"
FT   HELIX           379..398
FT                   /evidence="ECO:0007829|PDB:3SOC"
FT   STRAND          404..406
FT                   /evidence="ECO:0007829|PDB:3SOC"
FT   HELIX           416..419
FT                   /evidence="ECO:0007829|PDB:3SOC"
FT   HELIX           425..432
FT                   /evidence="ECO:0007829|PDB:3SOC"
FT   HELIX           443..446
FT                   /evidence="ECO:0007829|PDB:3SOC"
FT   HELIX           449..461
FT                   /evidence="ECO:0007829|PDB:3SOC"
FT   HELIX           466..468
FT                   /evidence="ECO:0007829|PDB:3SOC"
FT   HELIX           472..485
FT                   /evidence="ECO:0007829|PDB:3SOC"
SQ   SEQUENCE   513 AA;  57848 MW;  A89822E880979618 CRC64;
     MGAAAKLAFA VFLISCSSGA ILGRSETQEC LFFNANWEKD RTNQTGVEPC YGDKDKRRHC
     FATWKNISGS IEIVKQGCWL DDINCYDRTD CVEKKDSPEV YFCCCEGNMC NEKFSYFPEM
     EVTQPTSNPV TPKPPYYNIL LYSLVPLMLI AGIVICAFWV YRHHKMAYPP VLVPTQDPGP
     PPPSPLLGLK PLQLLEVKAR GRFGCVWKAQ LLNEYVAVKI FPIQDKQSWQ NEYEVYSLPG
     MKHENILQFI GAEKRGTSVD VDLWLITAFH EKGSLSDFLK ANVVSWNELC HIAETMARGL
     AYLHEDIPGL KDGHKPAISH RDIKSKNVLL KNNLTACIAD FGLALKFEAG KSAGDTHGQV
     GTRRYMAPEV LEGAINFQRD AFLRIDMYAM GLVLWELASR CTAADGPVDE YMLPFEEEIG
     QHPSLEDMQE VVVHKKKRPV LRDYWQKHAG MAMLCETIEE CWDHDAEARL SAGCVGERIT
     QMQRLTNIIT TEDIVTVVTM VTNVDFPPKE SSL
//
